Results 191 to 200 of about 22,851 (227)
Some of the next articles are maybe not open access.
Thromboprophylaxis in medical patients
Hospital Medicine, 2000Recent clinical studies have confirmed that acutely ill medical patients are at substantial risk of venous thromboembolism, which can be reduced by thromboprophylaxis with low molecular weight heparin. These studies have resulted in approval of a low molecular weight heparin (enoxaparin) for the prophylaxis of venous thromboembolism in medical patients
openaire +2 more sources
Thromboprophylaxis in cancer outpatients
Blood, 2008In this issue of Blood, Khorana and colleagues report a simple and practical model for the prediction of symptomatic venous thrombosis after the initiation of chemotherapy in cancer outpatients.
openaire +2 more sources
Emerging concepts in thromboprophylaxis
Pathophysiology of Haemostasis and Thrombosis, 2002Venous thromboembolism (VTE), comprising pulmonary embolism (PE) and deep vein thrombosis (DVT), is a common and potentially fatal disease. Since it is frequently asymptomatic, prevention is the most effective means to reduce morbidity and mortality. Although thromboprophylaxis is recommended in patients undergoing general and orthopaedic surgery and ...
openaire +2 more sources
Implementation of thromboprophylaxis guidelines.
Irish medical journal, 2013Venous thromboembolism (VTE) remains one of the leading direct causes of maternal death. Risk factors for VTE and prophylaxis guidelines have been highlighted by the Royal College of Obstetricians and Gynaecologists (RCOG). A cross sectional study was completed in Cork University Maternity Hospital (CUMH) to determine pattern of VTE risk and compliance
Cregan, A, Higgins, JR, O’Shea, S
openaire +2 more sources